RITALIN LA

LOE Approaching

methylphenidate

NDAORALCAPSULE, EXTENDED RELEASE
Approved
Jun 2002
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
20

Mechanism of Action

stimulant. The mode of therapeutic action in ADHD is not known.

Clinical Trials (5)

NCT05669170Phase 2Not Yet Recruiting

Methylphenidate for Apathy in Veterans With Parkinson's Disease

Started Jan 2024
60 enrolled
Parkinson DiseaseApathy
NCT04132557N/ACompleted

A Study on Suicidality, Psychosis or Substance Abuse With Methylphenidate, Atomoxetine, Amphetamine/Dextroamphetamine or Lisdexamfetamine

Started Oct 2019
430,000 enrolled
Attention Deficit Disorder With Hyperactivity
NCT03546400Phase 4Withdrawn

Safety, Tolerability and PK Study of Methylphenidate HCl ERCT in 4-5 Year Old Children With ADHD.

Started Sep 2018
0
Attention Deficit Hyperactivity Disorder (ADHD)
NCT03536390Phase 4Withdrawn

A 6-week Study to Evaluate the Safety and Efficacy of Methylphenidate HCl ERCT in 4-5 Year Old Children With ADHD

Started Sep 2018
0
Attention Deficit Hyperactivity Disorder
NCT02730572N/ACompleted

Concerta (Methylphenidate) -To-Generic Switch Study

Started Sep 2015
1,464 enrolled
Attention Deficit Disorder With Hyperactivity